These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22208029)

  • 1. [Neoadjuvant hormonal therapy before radical prostatectomy].
    Nakagawa T
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():485-7. PubMed ID: 22208029
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radical prostatectomy with neoadjuvant hormone therapy for cT3 prostate cancer].
    Fujimoto H
    Nihon Rinsho; 2005 Feb; 63(2):271-8. PubMed ID: 15714978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant hormonal therapy for prostate cancer].
    Miki T; Kamoi K
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):927-33. PubMed ID: 11478141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant hormone therapy with casodex in a dose 150 mg prior to radical prostatectomy in patients with prostatic cancer].
    Rusakov IG; Petrov SB; Alekseev BIa; Veliev EI
    Urologiia; 2004; (4):15-9. PubMed ID: 15457946
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neoadjuvant hormonal therapy for prostate cancer].
    Miyakita H
    Nihon Rinsho; 2005 Feb; 63(2):309-13. PubMed ID: 15714984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
    Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML
    Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.
    Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S;
    J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant androgen deprivation preceding to radical prostatectomy--its role in short-term and long-term outcomes].
    Homma Y
    Nihon Rinsho; 1998 Aug; 56(8):2162-6. PubMed ID: 9750527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy prior to radical prostatectomy: pro.
    Fair WR; Garnick MB
    Urology; 1996 Oct; 48(4):535-8. PubMed ID: 8886055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicopathological significance of neoadjuvant hormonal therapy prior to radical prostatectomy: whole section analysis].
    Uemura H; Cho M; Hirao Y; Konishi N
    Hinyokika Kiyo; 2002 Nov; 48(11):719-23. PubMed ID: 12512148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment results of radical prostatectomy in clinical stage B and C prostate cancer: comparison of the neoadjuvant therapy group versus the surgery group; retrospective analysis of 80 cases].
    Ogura Y; Sakata Y; Wakita T; Hayashi N; Hioki T; Sugimura Y
    Hinyokika Kiyo; 2003 Sep; 49(9):515-20. PubMed ID: 14598688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant hormone therapy: the Canadian trials.
    Klotz L; Gleave M; Goldenberg SL
    Mol Urol; 2000; 4(3):233-7;discussion 239. PubMed ID: 11062379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy for prostate cancer.
    Berry WR
    N C Med J; 2006; 67(2):154-7. PubMed ID: 16752722
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?
    Jani A; Vogelzang NJ
    J Urol; 2001 Aug; 166(2):631-2. PubMed ID: 11458102
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.
    Furukawa J; Miyake H; Takenaka A; Hara I; Fujisawa M
    BJU Int; 2007 Aug; 100(2):310-4. PubMed ID: 17511772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Sonpavde G; Chi KN; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Berry WR; Kadmon D
    Cancer; 2007 Dec; 110(12):2628-39. PubMed ID: 17941029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary treatment of high-risk localized prostate cancer.
    Tareen B; Kimmel J; Huang WC
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1069-76. PubMed ID: 20645696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
    Schulman CC; Wildschutz TP
    Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?
    Scolieri MJ; Altman A; Resnick MI
    J Urol; 2000 Nov; 164(5):1465-72. PubMed ID: 11025684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on androgen deprivation therapy prior to radical prostatectomy with special reference to the tumor volume].
    Hachiya T; Nogaki J; Ishida H; Okada K
    Nihon Rinsho; 1998 Aug; 56(8):2157-61. PubMed ID: 9750526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.